Literature DB >> 7214093

5-Hydroxytryptamine induces relaxation of goat pulmonary veins: evidence for the noninvolvement of M and D-tryptamine receptors.

N Chand.   

Abstract

1 Reactivity of goat isolated pulmonary arteries and veins to a variety of vasoactive agents was investigated. 2 Bradykinin (Bk), acetylcholine (ACh), noradrenaline (NA), prostaglandin A1 (PGA1), PGE2, PGF2 alpha and histamine induced dose-dependent contractile responses on veins; 5-hydroxytryptamine (5-HT) induced veno-relaxation. Angiotensin was virtually inactive. 3 Angiotensin, NA, Bk, histamine and 5-HT produced concentration-dependent contractile responses on the arterial strips; these arteries failed to respond to ACh, PGA1, PGE2 or PGF2 alpha. 4 The pulmonary veno-relaxant response to 5-HT was found to be resistant to propranolol, indomethacin, metiamide, cimetidine, methysergide, atropine and morphine. These findings appear to exclude the involvement of adrenergic mechanisms and prostaglandin generation as well as activation of classical M and D-tryptamine receptors by 5-HT in the goat pulmonary veins. This response may be mediated via a presynaptic inhibitory 5-HT receptor. 5 5-HT-induced arterial contractile responses were antagonized by methysergide, showing the occurrence of classical D receptors in the goat pulmonary artery. 6 It is concluded that differential reactivity of pulmonary arteries and veins to vasoactive agents may play differential role(s) in the pathophysiology of pulmonary disease. 5-HT may exert an antiinflammatory activity in goat pulmonary veins.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214093      PMCID: PMC2071513          DOI: 10.1111/j.1476-5381.1981.tb09118.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Release of smooth muscle-contracting substances from isolated perfused lungs.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Eur J Pharmacol       Date:  1976-02       Impact factor: 4.432

Review 2.  Vascular smooth muscle. II. Pharmacology of normal and hypotensive vessels.

Authors:  A P Somlyo; A V Somlyo
Journal:  Pharmacol Rev       Date:  1970-06       Impact factor: 25.468

3.  Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dog.

Authors:  B B Vargaftig; J Lefort
Journal:  Eur J Pharmacol       Date:  1974-02       Impact factor: 4.432

4.  Tryptophan-induced intersitial pulmonary emphysema in cattle.

Authors:  J R Carlson; I A Dyer; R J Johnson
Journal:  Am J Vet Res       Date:  1968-10       Impact factor: 1.156

5.  Comparisons of reactivity of pulmonary vascular and airway smooth muscle of sheep and calf to tryptamine analogues, histamine, and antigen.

Authors:  P Eyre
Journal:  Am J Vet Res       Date:  1975-08       Impact factor: 1.156

6.  Contractile responses of canine isolated pulmonary lobar arteries and veins to norepinephrine, serotonin, and tyramine.

Authors:  P D Joiner; P J Kadowitz; L B Davis; A L Hyman
Journal:  Can J Physiol Pharmacol       Date:  1975-10       Impact factor: 2.273

7.  Atypical tryptamine receptors in sheep pulmonary vein.

Authors:  P Eyre
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

8.  Pharmacology of bovine pulmonary vein anaphylaxis in vitro.

Authors:  P Eyre
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

9.  Induction of pulmonary edema and emphysema in cattle and goats with 3-methylindole.

Authors:  J R Carlson; M T Yokoyama; E O Dickinson
Journal:  Science       Date:  1972-04-21       Impact factor: 47.728

10.  Pharmacological significance of biogenic amines in the lungs: 5-hydroxytryptamine.

Authors:  C Sadavongvivad
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

View more
  10 in total

Review 1.  Pharmacological studies of pulmonary anaphylaxis in vitro: a review.

Authors:  P O Ogunbiyi; P Eyre
Journal:  Agents Actions       Date:  1985-12

2.  5-HT causes splanchnic venodilation.

Authors:  Bridget M Seitz; Hakan S Orer; Teresa Krieger-Burke; Emma S Darios; Janice M Thompson; Gregory D Fink; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

3.  Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins.

Authors:  L Walch; J P Gascard; E Dulmet; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Is the 5-hydroxytryptamine 7 Receptor Constitutively Active in the Vasculature? A Study in Veins/Vein.

Authors:  Stephanie W Watts; Emma D Flood; Janice M Thompson
Journal:  J Cardiovasc Pharmacol       Date:  2022-08-01       Impact factor: 3.271

Review 5.  Oh, the places you'll go! My many colored serotonin (apologies to Dr. Seuss).

Authors:  Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-23       Impact factor: 4.733

6.  Effects of mianserin, desipramine and maprotiline on blood pressure responses evoked by acetylcholine, histamine and 5-hydroxytryptamine in rats.

Authors:  I Cavero; F Lefèvre-Borg; A G Roach
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

7.  5-Hydroxytryptamine (5-HT) mediates potent relaxation in the sheep isolated pulmonary vein via activation of 5-HT4 receptors.

Authors:  T M Cocks; P J Arnold
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  The vascular responses of the isolated perfused bovine external ear to exogenous histamine and 5-HT (serotonin).

Authors:  K I Eghianruwa; P Eyre
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

9.  5-HT7 Receptor Restrains 5-HT-induced 5-HT2A Mediated Contraction in the Isolated Abdominal Vena Cava.

Authors:  Romina Gonzalez-Pons; Kiera McRae; Janice M Thompson; Stephanie W Watts
Journal:  J Cardiovasc Pharmacol       Date:  2021-08-01       Impact factor: 3.271

10.  5-HT is a potent relaxant in rat superior mesenteric veins.

Authors:  Stephanie W Watts; Emma S Darios; Bridget M Seitz; Janice M Thompson
Journal:  Pharmacol Res Perspect       Date:  2015-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.